title: Complete DNA sequences of two oka strain varicella-zoster virus genomes.
abstract: Varicella-zoster virus (VZV) is a herpesvirus and is the causative agent of chicken pox (varicella) and shingles (herpes zoster). Active immunization against varicella became possible with the development of live attenuated varicella vaccine. The Oka vaccine strain was isolated in Japan from a child who had typical varicella, and it was then attenuated by serial passages in cell culture. Several manufacturers have obtained this attenuated Oka strain and, following additional passages, have developed their own vaccine strains. Notably, the vaccines Varilrix and Varivax are produced by GlaxoSmithKline Biologicals and Merck & Co., Inc., respectively. Both vaccines have been well studied in terms of safety and immunogenicity. In this study, we report the complete nucleotide sequence of the Varilrix (Oka-V(GSK)) and Varivax (Oka-V(Merck)) vaccine strain genomes. Their genomes are composed of 124,821 and 124,815 bp, respectively. Full genome annotations covering the features of Oka-derived vaccine genomes have been established for the first time. Sequence analysis indicates 36 nucleotide differences between the two vaccine strains throughout the entire genome, among which only 14 are involved in unique amino acid substitutions. These results demonstrate that, although Oka-V(GSK) and Oka-V(Merck) vaccine strains are not identical, they are very similar, which supports the clinical data showing that both vaccines are well tolerated and elicit strong immune responses against varicella.
authors.affiliation: Viral Vaccines Research and Development, GlaxoSmithKline Biologicals, Rue de l'Institut, 89 (P31-005), B-1330 Rixensart, Belgium.
authors.forename: Sueli L
authors.initials: SL
authors.lastname: Tillieux
authors.forename: Wendy S
authors.initials: WS
authors.lastname: Halsey
authors.forename: Elizabeth S
authors.initials: ES
authors.lastname: Thomas
authors.forename: John J
authors.initials: JJ
authors.lastname: Voycik
authors.forename: Ganesh M
authors.initials: GM
authors.lastname: Sathe
authors.forename: Ventzislav
authors.initials: V
authors.lastname: Vassilev
mesh_terms: D019943:Amino Acid Substitution / Q000235:genetics; D001483:Base Sequence; D019433:Chickenpox Vaccine / Q000235:genetics*; D004279:DNA, Viral / Q000737:chemistry* / Q000235:genetics*; D005814:Genes, Viral; D016679:Genome, Viral; D014645:Herpesvirus 3, Human / Q000235:genetics*; D008969:Molecular Sequence Data; D011110:Polymorphism, Genetic; D017422:Sequence Analysis, DNA
chemical_list: D019433:Chickenpox Vaccine; D004279:DNA, Viral
references.citation: JAMA. 2002 Feb 6;287(5):606-11
references.pmid: 11829699
references.citation: MMWR Recomm Rep. 2007 Jun 22;56(RR-4):1-40
references.pmid: 17585291
references.citation: Pediatrics. 1986 Oct;78(4 Pt 2):748-56
references.pmid: 3020494
references.citation: J Virol. 2001 Oct;75(19):9483-92
references.pmid: 11533210
references.citation: J Med Virol. 2006 Dec;78(12):1679-87
references.pmid: 17063506
references.citation: Adv Exp Med Biol. 1990;278:83-91
references.pmid: 1963048
references.citation: J Infect Dis. 1996 Nov;174 Suppl 3:S310-3
references.pmid: 8896537
references.citation: Virology. 1992 Sep;190(1):221-32
references.pmid: 1326803
references.citation: Pediatrics. 1995 May;95(5):791-6
references.pmid: 7724330
references.citation: N Engl J Med. 2007 Mar 15;356(11):1121-9
references.pmid: 17360990
references.citation: Pediatr Infect Dis J. 2007 Jul;26(7):632-8
references.pmid: 17596807
references.citation: Vaccine. 2002 Dec 13;21(3-4):281-9
references.pmid: 12450703
references.citation: J Virol. 1992 Dec;66(12):7581-4
references.pmid: 1331541
references.citation: Vaccine. 1997 Jan;15(1):61-4
references.pmid: 9041667
references.citation: J Infect Dis. 1992 Aug;166 Suppl 1:S63-8
references.pmid: 1320652
references.citation: Pediatr Infect Dis J. 2007 Feb;26(2):153-8
references.pmid: 17259879
references.citation: Arch Virol Suppl. 2001;(17):81-9
references.pmid: 11339554
references.citation: J Clin Microbiol. 2005 Oct;43(10):5415-6; author reply 5416-7
references.pmid: 16208038
references.citation: Paediatr Drugs. 2001;3(4):285-92
references.pmid: 11354700
references.citation: Pediatr Infect Dis J. 2006 Jan;25(1):12-8
references.pmid: 16395096
references.citation: N Engl J Med. 1984 Nov 22;311(21):1362-4
references.pmid: 6092956
references.citation: Arch Virol Suppl. 2001;(17):1-6
references.pmid: 11339539
references.citation: Lancet. 1974 Nov 30;2(7892):1288-90
references.pmid: 4139526
references.citation: J Virol. 2002 Nov;76(22):11447-59
references.pmid: 12388706
references.citation: MMWR Recomm Rep. 1996 Jul 12;45(RR-11):1-36
references.pmid: 8668119
references.citation: Pediatr Infect Dis J. 2000 Feb;19(2):169-70
references.pmid: 10694011
references.citation: J Virol. 2006 Oct;80(19):9850-60
references.pmid: 16973589
references.citation: Pediatrics. 1991 May;87(5):604-10
references.pmid: 1850506
references.citation: N Engl J Med. 2002 Dec 12;347(24):1909-15
references.pmid: 12477940
references.citation: J Paediatr Child Health. 2005 Nov;41(11):544-52
references.pmid: 16398834
references.citation: J Virol. 2004 Jul;78(13):6799-807
references.pmid: 15194755
references.citation: J Clin Virol. 2006 Jun;36(2):111-8
references.pmid: 16616612
references.citation: Virology. 2000 Sep 30;275(2):306-17
references.pmid: 10998331
references.citation: Virology. 2004 May 20;323(1):85-90
references.pmid: 15165821
references.citation: Infection. 2007 Oct;35(5):326-33
references.pmid: 17710370
references.citation: Pediatr Infect Dis J. 2006 Jun;25(6):475-6
references.pmid: 16732142
references.citation: Wkly Epidemiol Rec. 1998 Aug 7;73(32):241-8
references.pmid: 9715106
references.citation: J Virol. 1995 Aug;69(8):4693-701
references.pmid: 7609034
references.citation: J Pediatr. 1995 Oct;127(4):518-25
references.pmid: 7562270
references.citation: J Infect Dis. 2008 Mar 1;197 Suppl 2:S49-53
references.pmid: 18419408
references.citation: BioDrugs. 2008;22(6):387-402
references.pmid: 18998756
references.citation: J Clin Microbiol. 2004 Dec;42(12):5604-8
references.pmid: 15583288
references.citation: Virology. 2005 Feb 5;332(1):337-46
references.pmid: 15661165
references.citation: J Virol. 1998 Feb;72(2):965-74
references.pmid: 9444989
references.citation: J Virol. 1987 Sep;61(9):2877-84
references.pmid: 3039175
references.citation: J Virol. 1992 Jan;66(1):359-66
references.pmid: 1309252
references.citation: Virology. 2007 Feb 20;358(2):291-302
references.pmid: 17027059
references.citation: Vaccine. 2002 Jul 26;20(23-24):2942-9
references.pmid: 12126906
references.citation: Hum Vaccin. 2006 Sep-Oct;2(5):205-14
references.pmid: 17035730
references.citation: JAMA. 2005 Aug 17;294(7):797-802
references.pmid: 16106004
references.citation: Postgrad Med J. 1985;61 Suppl 4:53-6
references.pmid: 3014478
references.citation: J Virol. 1993 Aug;67(8):4474-83
references.pmid: 8392592
references.citation: J Virol. 1994 Dec;68(12):7850-8
references.pmid: 7966575
references.citation: Eur J Pediatr. 2007 Aug;166(8):857-64
references.pmid: 17541639
references.citation: J Infect Dis. 2000 Mar;181(3):1153-7
references.pmid: 10720545
references.citation: Pediatr Infect Dis J. 2004 Feb;23(2):132-7
references.pmid: 14872179
references.citation: Virology. 1991 Oct;184(2):625-35
references.pmid: 1653492
references.citation: J Virol Methods. 2004 Jul;119(1):25-30
references.pmid: 15109817
references.citation: Arch Dis Child. 2008 Oct;93(10):845-50
references.pmid: 18456699
references.citation: Rev Med Virol. 2003 Jul-Aug;13(4):207-22
references.pmid: 12820183
references.citation: Herpes. 2000 Oct;7(3):60-65
references.pmid: 11867004
references.citation: J Med Virol. 2003;70 Suppl 1:S82-9
references.pmid: 12627494
references.citation: Virology. 1997 Aug 4;234(2):186-95
references.pmid: 9268149
references.citation: J Infect Dis. 1974 Dec;130(6):669-72
references.pmid: 4372275
references.citation: J Med Virol. 2000 Aug;61(4):497-503
references.pmid: 10897069
references.citation: J Virol. 2008 Jan;82(2):795-804
references.pmid: 17977964
references.citation: J Infect Dis. 1996 Nov;174 Suppl 3:S324-9
references.pmid: 8896540
references.citation: Vaccine. 2000 Nov 22;19(7-8):916-23
references.pmid: 11115716
references.citation: J Infect Dis. 2008 Mar 1;197 Suppl 2:S45-8
references.pmid: 18419407
references.citation: Curr Opin Investig Drugs. 2002 Jul;3(7):996-9
references.pmid: 12186278
references.citation: Virology. 2007 Mar 15;359(2):447-58
references.pmid: 17069870
references.citation: Arch Virol Suppl. 2001;(17):49-56
references.pmid: 11339550
references.citation: Virology. 2001 Feb 1;280(1):1-6
references.pmid: 11162813
references.citation: J Med Virol. 2005 Jan;75(1):174-80
references.pmid: 15543576
references.citation: N Engl J Med. 1991 Nov 28;325(22):1545-50
references.pmid: 1658650
references.citation: J Gen Virol. 1986 Sep;67 ( Pt 9):1759-816
references.pmid: 3018124
references.citation: Arch Virol Suppl. 2001;(17):17-25
references.pmid: 11339546
references.citation: Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):208-12
references.pmid: 17182747
references.citation: Virology. 2001 Jun 5;284(2):153-8
references.pmid: 11384215